Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori

Helicobacter

Volumn 11, Issue 2, 2006, Pages 113-122

  Hatzifoti, Caterina ^a,e   Roussel, Yvonne ^a   Harris, Andrew G ^a   Wren, Brendan W ^b   Morrow, John W ^c   Bajaj Elliott, Mona ^d  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c InBios International Inc   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cytosine preceding guanosine motifs; Defensin gene expression; Helicobacter pylori; IL 10: IFN expression ratio; Interferon secretion; Murine stomach; Splenocyte proliferation; Urease B subunit

Indexed keywords

BETA DEFENSIN; CYTOKINE; CYTOSINE; DNA VACCINE; GAMMA INTERFERON; GUANOSINE; HELICOBACTER PYLORI VACCINE; INTERLEUKIN 10; RNA; UNCLASSIFIED DRUG; UREASE B DNA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; CANCER RISK; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNIZATION; INNATE IMMUNITY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; STOMACH; STOMACH ADENOCARCINOMA; STOMACH MUCOSA;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; BETA-DEFENSINS; CELL PROLIFERATION; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTRIC MUCOSA; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNITY, NATURAL; LYMPHOCYTES; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPLEEN; UREASE; VACCINES, DNA;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; MURINAE;

EID: 33644844581     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2006.00385.x     Document Type: Article

References (60)

1. Hazell SL Hennessy WB Borody TJ et al. Campylobacter pyloridis gastritis II: distribution of bacteria and associated inflammation in the gastroduodenal environment Am J Gastroenterol 1987 82 297 301
2. Graham D. Campylobacter pylori and peptic ulcer disease Gastroenterology 1989 96 615 25
3. Morgner A Sutton P O'Rourke JL et al. Helicobacter-induced expression of Bcl-X (L) in B lymphocytes in the mouse model: a possible step in the development of gastric mucosa-associated lymphoid tissue (MALT) lymphoma Int J Cancer 2001 92 634 40
4. Uemura N Okamoto S Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer N Engl J Med 2001 345 784 9
5. Feldman RA Eccersley AJ Hardie GM. Transmission of Helicobacter pylori Curr Opinion Gastroenterol 1997 13S1 8 12
6. Mobley HLT. Urease. In Mobley HLT Mendz GL Hazell SL eds Helicobacter pylori: Physiology and Genetics Washington, DC American Society for Microbiology Press 2001 179
7. Eaton KA Brooks CL Morgan DR Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets Infect Immun 1991 59 2470 5
8. Takahashi S Igarashi H Nakamura K et al. Helicobacter pylori and urease activity: comparative study between urease-positive and -negative mutant strains Nippon Rhinso - Jpn J Clin Med 1993 51 3149 53
9. Tsuda M Karita M Morshed G et al. A urease-negative mutant of Helicobacter pylori constructed by allelic exchange lacks the ability to colonise the nude mouse stomach Infect Immun 1994 62 3586 9
10. Hu LT Mobley HL. Purification and amino-terminal analysis of urease from Helicobacter pylori Infect Immun 1990 58 992 8
11. Mobley H Garner R Bauerfeind P. Helicobacter pylori nickel-transport gene nixA: synthesis of catalytically active urease in Escherichia coli independent of growth conditions Mol Microbiol 1995 16 97 109
12. Lee A O'Rourke J De Ungria M et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain Gastroenterology 1997 112 1386 97
13. Sutton P O'Rourke J Wilson J et al. Immunisation against Helicobacter felis infection protects against the development of gastric MALT lymphoma Vaccine 2004 22 2541 6
14. Lee CK Weltzin R Thomas WD et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis J Infect Dis 1995 172 161 72
15. Hatzifoti C Wren BW Morrow WJ. Helicobacter pylori vaccine strategies: triggering a gut reaction Immunol Today 2000 21 615 9
16. Nedrud JG Blanchard SS Czinn SJ. Helicobacter pylori inflammation and immunity Helicobacter 2002 7 24 9
17. Garhart CA Heinzel FP Czinn SJ Nedrud JG. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin 12 dependent but gamma interferon and inducible nitric oxide synthase independent Infect Immun 2003 71 910 21
18. Sommer F Wilken H Faller G Lohoff M. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis Infect Immun 2004 72 1029 35
19. Blanchard TG Eisenberg JC Matsumoto Y. Clearance of Helicobacter pylori infection through immunization: the site of T-cell activation contributes to vaccine efficacy Vaccine 2004 17 888 97
20. Akhiani AA Schon K Franzen LE et al. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection N J Immunol 2004 15 5024 33
21. Blaser MJ Atherton JC. Helicobacter pylori persistence: biology and disease J Clin Invest 2004 113 321 33
22. Gobert AP Bambou JC Werts C et al. Helicobacter pylori heat-shock protein 60 mediates interleukin 6 production by macrophages via a Toll-like receptor (TLR) -2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism J Biol Chem 2004 279 245 50
23. Todoroki I Joh T Watanabe K et al. Suppressive effects of DNA vaccines encoding heat-shock protein on Helicobacter pylori-induced gastritis in mice Biochem Biophys Res Commun 2000 277 159 63
24. Miyashita M Joh T Watanabe K et al. Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori catalase Vaccine 2002 20 2336 42
25. Wagner H. The immunobiology of the TLR9 subfamily Trends Immunol 2004 7 381 6
26. Sparwasser T Koch ES Vabulas RM. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells Eur J Immunol 1998 28 2045 54
27. Klinman DM Yamshchikov G Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines J Immunol 1997 158 3635 9
28. Shi T Liu WZ Gao F. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection Helicobacter 2005 10 71 9
29. Gomis S Babiuk L Allan B et al. Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine- phosphodiester-guanine motifs Avian Dis 2004 48 813 22
30. Gomis S Babiuk L Godson DL et al. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs Infect Immun 2003 71 857 63
31. Elkins KL Rhinehart-Jones TR Stibitz S et al. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria J Immunol 1999 1 62 2291 8
32. Krieg AM. CpG motifs in bacterial DNA and their immune effects Annu Rev Immunol 2002 20 709 60
33. + T cells Clin Exp Immunol 2005 140 220 9
34. Wada A Mori N Oishi K et al. Induction of human beta-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island Biochem Biophys Res Commun 1999 263 770 4
35. Bajaj-Elliott M Fedeli P Smith GV et al. Modulation of host antimicrobial peptide ({beta}-defensins 1 and 2) expression during gastritis Gut 2002 51 356 61
36. George JT Boughan PK Karageorgiou H Bajaj-Elliott M. Host antimicrobial response to Helicobacter pylori infection Mol Immunol 2003 40 451 6
37. Hase K Murakami M Iimura M et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori Gastroenterology 2003 125 1613 25
38. Hatzifoti C Bajaj-Elliott M Dorrell N et al. A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and up-regulates the expression of beta-defensins and IL-10 in the stomachs of immunized mice Vaccine 2004 22 2651 9
39. Harris AG Wilson JE Danon SG et al. Catalase (KatA) and KatA-associated protein (KapA) are essential for persistent colonization in the Helicobacter pylori SS1 mouse model Microbiology 2003 149 665 72
40. Roussel Y Wilks M Harris A et al. Evaluation of DNA extraction methods from mouse stomachs for the quantification of H. pylori by real-time PCR J Microbiol Meth 2005 62 71 81
41. Allen PD Newland AC. Cell viability, necrosis and apoptosis In McCarthy DA Macey MG eds Cytometric Analysis of Cell Phenotype and Function 2001 193 6 Cambridge University Press Cambridge
42. Ermak TH Giannasca PJ Nichols R et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC Class II-restricted responses J Exp Med 1998 188 2277 88
43. Chen W Shu D Chadwick VC. Helicobacter pylori infection in interleukin 4-deficient and transgenic mice Scand J Gastroenterol 1999 34 987 92
44. Aebischer T Laforsch S Hurwitz R et al. Immunity against Helicobacter pylori: Significance of interleukin 4 receptor chain status and gender of infected mice Infect Immun 2001 69 556 8
45. + T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin 4 (IL-4)/IL-13 receptor signaling Infect Immun 2001 69 1714 22
46. Smythies L Waites KB Lindsey JR et al. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice J Immunol 2002 165 1022 9
47. Akhiani AA Pappo J Kabok Z et al. Protection against Helicobacter pylori infection following immunization is IL-12 dependent and mediated by Th1 Cells J Immunol 2002 169 6977 84
48. Stober CB Lange UG Roberts MT Alcami A Blackwell JM. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection J Immunol 2005 175 2517 24
49. Ganz T. Defensins: antimicrobial peptides of innate immunity Nat Rev Immunol 2003 3 710 20
50. Huttner K Kozak C Bevins C. The mouse genome encodes a single homolog of the antimicrobial peptide human [beta]-defensin 1 FEBS Lett 1997 413 45 9
51. Bals R Wang X Meegalla RL et al. Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs Infect Immun 1999 67 3542 7
52. Simmons CP Goncalves NS Ghaem-Maghami M et al. Impaired resistance and enhanced pathology during infection with a non-invasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-{gamma} J Immunol 2002 168 1804 12
53. Zaalouk TK Bajaj-Elliott M George JT McDonald V. Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection Infect Immun 2004 72 2772 9
54. He Q Wang JP Osato M Lachman LB. Real-time quantitative PCR for detection of Helicobacter pylori J Clin Microbiol 2002 40 3720 8
55. Kobayashi D Eishi Y Ohkusa T et al. Gastric mucosal density of Helicobacter pylori estimated by real-time PCR compared with results of urea breath test and histological grading J Med Microbiol 2002 51 305 11
56. Blom K Svennerholm A Bïlin I. The expression of the Helicobacter pylori genes ureA and nap is higher in vivo than in vitro as measured by quantitative competitive reverse transcriptase-PCR FEMS Immunol Med Microbiol 2002 32 219 26
57. Ozpolat B Rao XM Lachman LB et al. Quantitative and bioluminescent assay to measure efficacy of conventional and DNA vaccinations against Helicobacter pylori Comb Chem High Throughput Screen 2002 3 289 302
58. Davila E Celis A. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity J Immunol 2000 165 539 47
59. Rosinha GM Myioshi AN Azevedo VA et al. Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate- dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin 12-expressing plasmid in a DNA vaccine formulation J Med Microbiol 2002 51 661 71
60. Svanholm C Bandholt L Castanos-Velez E et al. Protective DNA immunization against Chlamydia pneumoniae Scand J Immunol 2001 51 345 53